Abstract Background CD276 (also known as B7-H3) is one of the most important immune checkpoints of the CD28 and B7 superfamily. and its abnormal expression is closely associated with various types of cancer. It has been shown that CD276 is able to inhibit the function of T cells. and that this gene may potentially be a promising immunotherapy target for different types of cancer. https://www.lightemupsequences.com/flash-pick-ABC-Always-Be-Coding-Poster-top-savings/